ID   Panc02-H7
AC   CVCL_D628
DR   Wikidata; Q54937553
RX   PubMed=11558631;
RX   PubMed=22208613;
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
RX   PubMed=11558631; DOI=10.1385/IJGC:29:1:37;
RA   Wang B.-L., Shi Q., Abbruzzese J.L., Xiong Q.-H., Le X.-D., Xie K.-P.;
RT   "A novel, clinically relevant animal model of metastatic pancreatic
RT   adenocarcinoma biology and therapy.";
RL   Int. J. Pancreatol. 29:37-46(2001).
//
RX   PubMed=22208613; DOI=10.2174/156652412799218868; PMCID=PMC3799885;
RA   Wang Y., Zhang Y., Yang J., Ni X., Liu S., Li Z., Hodges S.E.,
RA   Fisher W.E., Brunicardi F.C., Gibbs R.A., Gingras M.-C., Li M.;
RT   "Genomic sequencing of key genes in mouse pancreatic cancer cells.";
RL   Curr. Mol. Med. 12:331-341(2012).
//